Turn on more accessible mode

Turn off more accessible mode

Skip Ribbon Commands

Skip to main content

Turn off Animations

Turn on Animations

Pharma RFP/Invitation Notices

Terms and Conditions:

All RFP proposals must be submitted through the Ariba sourcing tool.
Your company must be registered in Singapore to participate in ALPS events.
For all events, the Supply Head requirement for participation is EPU/DAP/32.
Each Company must participate at all sourcing events through or using the same Ariba account.

You can gain direct access into events by following the steps outlined below:

Click on the respective link found in the column “Respond to Posting”. You will be directed to the next page
Click on the “Respond to Posting” button found on the page
Log in to Ariba by entering your Ariba ID and password
You will gain access into the event for proposal submission
Submit your proposal in the Ariba sourcing tool before the closing date and time stated in the RFP notice below

Contact Persons:

Genesis Lim (Tel: 6377 8737)

Kang Mei Ting (Tel: 6377 8974)

Neo Li Zhu (Tel: 6377 8432)

Tai Ai Lee (Tel: 6377 8734)

Purchasing Programme

Evaluation Criteria

Evaluation Criteria (Unregistered Drugs)

RFP Results (Updated on 16 January 2025)

Estimated Annual Quantities

RFP/Invitation Notices

RFP No	Event Description	RFP Document	Published Date	Closing Date/time	Respond to Posting	Financial Category	Corrigendum	Remarks
GPOR 03525	Items 1 to 2 - Unregistered Drugs	GPOR 03525	17/01/2025	7/2/2025 12:00 PM	https://discovery.ariba.com/rfx/22110392	S3 or higher	No
GPOV 00125	Item 1 - Selumetinib 10mg Hard Capsules Item 2 - Selumetinib 25mg Hard Capsules	GPOV 00125	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22032505	S7 or Higher	No
GPOR 03425	Item 1 - Semaglutide 2mg/1.5mL pre-filled pen Item 2 - Semaglutide 4mg/3mL pre-filled pen	GPOR 03425	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22067552	S8 or higher	No
GPOR 03325	Item 1 - Terazosin 5mg Tablets	GPOR 03325	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22059669	S4 or higher	No
GPOR 03225	Item 1 - Sacubitril 24.3mg and Valsartan 25.7mg Tablets Item 2 - Sacubitril 48.6mg and Valsartan 51.4mg Tablets Item 3 - Sacubitril 97.2mg and Valsartan 102.8mg Tablets	GPOR 03225	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22059481	S8 or higher	No
GPOR 03125	Item 1 - Aluminium Chloride Hexahydrate 20% w/v Solution, 75mL bottle Item 2 - Hydrochlorothiazide 25mg and Triamterene 50mg Tablets Item 3 - Dinoprostone 3mg Vaginal Tablets Item 4 - Dienogest 2mg Tablets Item 5 - Haemorrhoidal Ointment,15g tube	GPOR 03125	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22059196	S6 or higher	No
GPOR 03025	Items 1 to 2 - Unregistered Drugs	GPOR 03025	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22031040	S2 or Higher	No
GPOR 02925	Item 1 - Potassium Chloride 20mmol/L In Dextrose 5% / Sodium Chloride 0.45% Inf Item 2 - Potassium Chloride 20mmol/L In Dextrose 5% / Sodium Chloride 0.9% Inf	GPOR 02925	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22045168	S5 or Higher	No
GPOR 02825	Item 1 - Insulin Degludec 70%, Insulin Aspart 30% 300 IU/3mL, 3mL pre-filled pen	GPOR 02825	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22045016	S3 or Higher	No
GPOR 02725	Item 1 - Semaglutide 3mg Tablets Item 2 - Semaglutide 7mg Tablets Item 3 - Semaglutide 14mg Tablets	GPOR 02725	10/01/2025	31/1/2025 12:00 PM	https://discovery.ariba.com/rfx/22058775	S6 or higher	No